Patents by Inventor David Andreu Martinez

David Andreu Martinez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PEPTIDE COMPOUNDS FOR REDUCING SIDE EFFECTS OF CB1 RECEPTOR AGONISTS
    Publication number: 20240059737
    Abstract: The present invention relates to compounds of formula (I) AA1-AA2-D-Ile-AA3-D-Met-D-Tyr-D-Ala-D-Tyr-D-Val-D- Ala-Gly-D-Ile-D-Leu-D-Lys-D-Arg-D-Trp-NH2 (I) or a pharmaceutically acceptable salts thereof, to processes for their obtention and to their therapeutic indications.
    Type: Application
    Filed: October 2, 2020
    Publication date: February 22, 2024
    Inventors: Vicent CASADÓ BURILLO, Estefania MORENO GUILLEN, Rafael MALDONADO LÓPEZ, David ANDREU MARTINEZ, Maria GALLO, Leonardo PARDO CARRASCO, Miguel CASTANHO, Vera NEVES, Marco CAVACO
  • Procedure for obtaining carbocalcitonin
    Patent number: 5739272
    Abstract: A procedure for obtaining carbocalcitonin comprising the condensation of fragment 1, a docosapeptide corresponding to the carboxamide end of the carbocalcitonin sequence, conveniently protected and anchored on resin, with fragment 2 or 3, a nonapeptide corresponding to the amino end of the salmon calcitonin sequence, with a ready-formed cycle between the Asu and Ser residua, and the treatment of the complete peptide skeleton (fragment 6 or 7) with an acid to free the totally deprotected peptide from the resin.
    Type: Grant
    Filed: February 3, 1994
    Date of Patent: April 14, 1998
    Assignee: Lipotec, S.A.
    Inventors: Marcos Canas Poblet, Berta Ponsati Obiols, Gemma Jodas Farres, David Andreu Martinez